A Case of Type 2 Diabetes Mellitus with Lung Cancer Suffered from Euglycemic Diabetic Ketosis Accompanied by Adrenal Insufficiency after Immune Checkpoint Inhibitors
A 74-year-old patient with type 2 diabetes mellitus received basal-bolus insulin, insulin secretagogues, and sodium glucose transporter 2 (SGLT2) inhibitors. After immune checkpoint inhibitor treatment for lung cancer, he suffered from depressed consciousness with a urinary ketone body (3+). When al...
Main Authors: | Saeko Shibasaki, Chisei Noda, Akihisa Imagawa, Sadaki Sakane |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2024-01-01
|
Series: | Case Reports in Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2024/9982174 |
Similar Items
-
Prolonged Ketosis in a Patient With Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin
by: Shreya Pujara MD, et al.
Published: (2017-05-01) -
Two types of fulminant type 1 diabetes mellitus: Immune checkpoint inhibitor‐related and conventional
by: Akihisa Imagawa
Published: (2021-06-01) -
Euglycemic Diabetic Ketoacidosis in Pregnancy
by: Júlio César Garcia de Alencar, et al.
Published: (2020-02-01) -
Euglycemic diabetic ketoacidosis associated with uremia
by: Mingxia Zhang, et al.
Published: (2021-02-01) -
Sodium glucose transporter 2 inhibition, euglycemic ketosis and bone mineral loss: Refining clinical practices
by: Deep Dutta, et al.
Published: (2015-01-01)